• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Candriam Equities L Biotechnology

+ Add to Watchlist

XUJ4:GR

345.0000 EUR 2.8500 0.82%

As of 15:45:06 ET on 09/23/2014.

Snapshot for Candriam Equities L Biotechnology (XUJ4)

Open: 348.9300 High - Low: 349.9200 - 344.6600 Primary Exchange: Berlin
Volume: 0 52-Week Range: 244.7100 - 355.3500 Beta vs BTK: 0.8206

ETF Chart for XUJ4

No chart data available.
  • XUJ4:GR 346.2860
  • 1D
  • 1M
  • 1Y
347.8500
Interactive XUJ4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XUJ4

Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: 2000-04-06 Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for XUJ4

NAV -
Assets (M) (on 2014-09-22) 611.0911
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for XUJ4

No dividends reported

Performance for XUJ4

1-Month +5.20% 1-Year +32.18%
3-Month +14.71% 3-Year +42.88%
Year To Date +28.15% 5-Year +29.42%
Expense Ratio 1.77

Top Fund Holdings for XUJ4

Filing Date: 07/31/2014
Name Position Value % of Total
Gilead Sciences Inc 538,000 49,253,900 8.777%
Celgene Corp 558,000 48,629,700 8.666%
Amgen Inc 353,000 44,968,670 8.013%
Biogen Idec Inc 114,850 38,404,692 6.844%
Alexion Pharmaceuticals Inc 176,500 28,061,735 5.001%
Regeneron Pharmaceuticals Inc 74,500 23,558,390 4.198%
Vertex Pharmaceuticals Inc 206,000 18,315,460 3.264%
Illumina Inc 106,000 16,950,460 3.021%
BioMarin Pharmaceutical Inc 201,000 12,425,820 2.214%
Salix Pharmaceuticals Ltd 87,000 11,476,170 2.045%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil